Yahoo
NYSE - Delayed Quote USD

Doximity, Inc. (DOCS)

24.89 -0.09 (-0.36%)
At close: May 4 at 4:00:02 PM EDT
25.18 +0.29 (+1.17%)
Pre-Market: 8:51:42 AM EDT
Trade DOCS on Coinbase
Chart Range Bar
Loading chart for DOCS
  • Previous Close 24.98
  • Open 24.98
  • Bid --
  • Ask --
  • Day's Range 24.55 - 25.67
  • 52 Week Range 20.55 - 76.51
  • Volume 2,815,629
  • Avg. Volume 3,460,788
  • Market Cap (intraday) 4.686B
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) 20.92
  • EPS (TTM) 1.19
  • Earnings Date May 13, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 37.77

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

www.doximity.com

830

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview: DOCS

Trailing total returns as of 5/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DOCS
43.79%
S&P 500 (^GSPC)
5.19%

1-Year Return

DOCS
58.05%
S&P 500 (^GSPC)
26.63%

3-Year Return

DOCS
27.50%
S&P 500 (^GSPC)
77.31%

5-Year Return

DOCS
39.54%
S&P 500 (^GSPC)
72.90%

Earnings Trends: DOCS

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 185.05M
Earnings 91.14M

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
50M
100M
150M

Analyst Insights: DOCS

View More

Analyst Price Targets

25.00
37.77 Average
24.89 Current
55.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/20/2026
Analyst Truist Securities
Rating Action Downgrade
Rating Hold
Price Action Lowers
Price Target 37 -> 29

Statistics: DOCS

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    4.60B

  • Enterprise Value

    3.87B

  • Trailing P/E

    20.99

  • Forward P/E

    15.80

  • PEG Ratio (5yr expected)

    0.69

  • Price/Sales (ttm)

    7.87

  • Price/Book (mrq)

    4.71

  • Enterprise Value/Revenue

    6.10

  • Enterprise Value/EBITDA

    15.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    37.54%

  • Return on Assets (ttm)

    12.84%

  • Return on Equity (ttm)

    23.82%

  • Revenue (ttm)

    637.78M

  • Net Income Avi to Common (ttm)

    239.4M

  • Diluted EPS (ttm)

    1.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    735.13M

  • Total Debt/Equity (mrq)

    1.09%

  • Levered Free Cash Flow (ttm)

    213.63M

Compare To: DOCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: DOCS

Fair Value

24.89 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: DOCS

View More
  • What does Argus have to say about DOCS?

    Doximity Inc has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target
  • Raising target price to $23.00

    Doximity Inc has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target
  • What does Argus have to say about DOCS?

    Doximity Inc has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target
  • Lowering target price to $21.00

    Doximity Inc has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: